Professor Brendan Jenkins
This invited review summarises the most recent findings about the interleukin-6 cytokine family in infectious diseases, inflammatory disorders and cancers, and the current strategies (and outcomes) in the clinic to block the actions of these cytokines against these diseases.
Centre for Innate Immunity & Infectious Diseases
Cancer and Immune Signalling Laboratory
Journal and article title
The diverse breadth of immune-related responses that these cytokines can regulate, and how they impact on the above disease states.
Providing a timely and urgently needed review - to basic and clinical researchers - of the literature on the targeting of these cytokines in the above disease states, as well as perspectives on what the current gaps in knowledge are and how they can be addressed.
Inflammation and cancer